Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults

Growth Hormone and IGF Research

Volumn 14, Issue SUPPL. A, 2004, Pages

  Feldt Rasmussen, Ulla ^a   Wilton, Patrick ^b   Jonsson, Peter ^b  

^a Rigshospitalet   (Denmark)

^b PFIZER INC   (United States)

Author keywords

Elderly; Growth hormone deficiency; Growth hormone replacement; Hypopituitarism

Indexed keywords

HUMAN GROWTH HORMONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANTHROPOMETRY; ARTHRALGIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DATA ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG SAFETY; EDEMA; FEMALE; FLUID RETENTION; GERIATRIC PATIENT; GLUCOSE METABOLISM; GROUPS BY AGE; GROWTH HORMONE DEFICIENCY; HEADACHE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NEOPLASM; ONSET AGE; PATIENT SELECTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SIDE EFFECT; STROKE;

EID: 2642536109     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2004.03.013     Document Type: Article

References (39)

1. P.V. Carroll, E.R. Christ, B.-Å. Bengtsson, Growth Hormone Research Society Scientific Committee, Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review, J. Clin. Endocrinol. Metab. 83 (1998) 382-395.
2. J.O.L. Jorgensen, S.A. Pedersen, L. Thuesen, J. Jorgensen, T. Ingemann-Hansen, N.E. Skakkebaek, J.S. Christiansen, Beneficial effects of growth hormone treatment in GH-deficient adults, Lancet I (1989) 1221-1225.
3. F. Salomon, R.C. Cuneo, R. Hesp, P. Sönksen, The effects of treatment with recombinant human growth hormone on body composition and metabolism in patients with growth hormone deficiency, N. Engl. J. Med. 321 (1989) 1803-1979.
4. H.M Whitehead, C. Boreham, E.M. McIlrath, B. Sheridan, L. Kennedy, A.B. Atkinson, D.R. Hadden, Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo-controlled cross-over study, Clin. Endocrinol. (Oxf.) 36 (1992) 45-52.
5. A. Binnerts, G.R. Swart, J.H. Wilson, N. Hoogerbrugge, H.A. Pols, J.C. Birkenhager, S.W. Lamberts, The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition, Clin. Endocrinol. (Oxf.) 37 (1992) 79-87.
6. B.-A. Bengtsson, S. Eden, L. Lonn, H. Kvist, A. Stokland, G. Lindstedt, I. Bosaeus, J. Tolli, L. Sjostrom, O.G. Isaksson, Treatment of adults with growth hormone deficiency with recombinant human growth hormone, J. Clin. Endocrinol. Metab. 76 (1993) 309-317.
7. J.U. Weaver, J.P. Monson, K. Noonan, W.G. John, A. Edwards, K.A. Evans, J. Cunningham, The effect of low dose recombinant growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults, J. Clin. Endocrinol. Metab. 80 (1995) 153-159.
8. G. Johannsson, T. Rosén, I. Bosaeus, L. Sjostrom, B.-Å. Bengtsson, Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary adults with adult-onset GH deficiency, J. Clin. Endocrinol. Metab. 81 (1996) 2865-2873.
9. D. Rudman, M.H. Kutner, C.M. Rogers, M.F. Lubin, G.A. Fleming, R.P. Bain, Impaired growth hormone secretion in the adult population: relation to age and adiposity, J. Clin. Invest. 67 (1981) 1361-1369.
10. A. Iranmanesh, G. Lizarralde, J.D. Veldhuis, Age and relative obesity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men, J. Clin. Endocrinol. Metab. 73 (1991) 1081-1088.
11. E. Corpas, S.M. Harman, M.R. Blackman, Human growth hormone and human aging, Endocr. Rev. 14 (1993) 20-39.
12. N. Vahl, J.O. Jorgensen, A.G. Jurik, J.S. Christiansen, Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults, J. Clin. Endocrinol. Metab. 81 (1996) 2209-2215.
13. A. Binnerts, J.H.P. Wison, S.J.W. Lamberts, The effects of human growth hormone administration in elderly adults with recent weight loss, J. Clin. Endocrinol. Metab. 67 (1988) 1312-1316.
14. D. Rudman, A.G. Feller, H.S. Nagraj, G.A. Gergans, P.Y. Lalitha, A.F. Goldberg, R.A. Schlenker, L. Cohn, I.W. Rudman, D.E. Mattson, Effects of human growth hormone in men over 60 years old, N. Engl. J. Med. 323 (1990) 1-6.
15. M.A. Papadakis, D. Grady, D. Black, M.J. Tierney, G.A. Gooding, M. Schambelan, C. Grunfeld, Growth hormone replacement in healthy older men improves body composition but not functional ability, Ann. Intern. Med. 124 (1996) 708-716.
16. L. Holloway, G. Butterfield, R. Hintz, N. Gesundheit, R. Marcus, Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women, J. Clin. Endocrinol. Metab. 79 (1994) 470-479.
17. D.R. Taafe, L. Pruitt, J. Reim, R.L. Hintz, G. Butterfield, A.R. Hoffman, R. Marcus, Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men, J. Clin. Endocrinol. Metab. 79 (1994) 1361-1366.
18. D.R. Taafe, I.U. Jin, T.H. Vu, A.R. Hoffman, R. Marcus, Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance trained elderly men, J. Clin. Endocrinol. Metab. 81 (1996) 421-425.
19. S. Welle, C. Thornton, M. Statt, B. McHenry, Growth hormone increases muscle mass and strength but does not rejuvenate neurofibrillar protein synthesis in healthy subjects over 60 years old, J. Clin. Endocrinol. Metab. 81 (1996) 3239-3243.
20. E. Corpas, S.M. Harman, M.A. Pineyro, R. Robertson, M.R. Blackman, Growth hormone (GH)-releasing hormone (1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men, J. Clin. Endocrinol. Metab. 75 (1992) 530-535.
21. J. Vittone, M.R. Blakman, J. Busby-Whitehead, C. Tsiao, K.J. Stewart, J. Tobin, T. Stevens, M.F. Bellantoni, M.A. Rogers, G. Baumann, J. Roth, S.M. Harman, R.G. Spencer, Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men, Metabolism 46 (1997) 1-9.
22. E. Arvat, L. Gianotti, S. Grottoli, B.P. Imbimbo, V. Lenaerts, R. Deghenghi, F. Camanni, E. Ghigo, Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects, J. Clin. Endocrinol. Metab. 79 (1994) 1440-1443.
23. E. Ghigo, E. Arvat, G. Rizzi, J. Bellone, M. Nicolosi, G.M. Boffano, M. Mucci, M.F. Boghen, F. Camanni, Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration, J. Endocrinol. Invest. 17 (1994) 157-162.
24. D.M. Hoffman, A.J. O'Sullivan, R.C. Baxter, K.K.Y. Ho, Diagnosis of growth hormone deficiency in adults, Lancet 343 (1994) 1064-1068.
25. A.A. Toogood, P.A. O'Neill, S.M. Shalet, Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years, J. Clin. Endocrinol. Metab. 81 (1996) 460-465.
26. A.A. Toogood, J.E. Adams, P.A. O'Neill, S.M. Shalet, Body composition in growth hormone deficient adults over the age of 60 years, Clin. Endocrinol. (Oxf.) 45 (1996) 399-405.
27. A.A. Toogood, S. Shalet, Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study, J. Clin. Endocrinol. Metab. 84 (1999) 131-136.
28. R. Fernholm, M. Bramnert, E. Hagg, A. Hilding, D.J. Baylink, S. Mohan, M. Thoren, Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease, J. Clin. Endocrinol. Metab. 85 (2000) 4104-4112.
29. J.P. Monson, R. Abs, B.-Å. Bengtsson, H. Bennmarker, U. Feldt-Rasmussen, E. Hernberg-Ståhl, M. Thoren, B. Westberg, P. Wilton, C. Wuster, Growth hormone deficiency and replacement in elderly pituitary adults, Clin. Endocrinol. (Oxf.) 53 (2000) 281-289.
30. W.M. Drake, D. Coyte, C. Camacho-Hübner, N.M. Jivanji, G. Kaltsas, D.F. Wood, P.J. Trainer, A.B. Grossman, G.M. Besser, J.P. Monson, Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults, J. Clin. Endocrinol. Metab. 83 (1998) 3913-3919.
31. R.F. Lie, J.M. Schmidt, K.J. Pierre, N. Gochman, Cholesterol oxidase based determination by continuous-flow analysis of total and free cholesterol in serum, Clin. Chem. 22 (1976) 1627.
32. M.F. Lopez-Virella, P. Stone, S. Ellis, J.A. Colvell, Cholesterol determination in high density lipoproteins separated by three different methods, Clin. Chem. 23 (1977) 882-884.
33. P. Fossati, L. Prencipe, Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide, Clin. Chem. 28 (1982) 2077.
34. W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin. Chem. 18 (1972) 439-502.
35. S.J. Holmes, S.M. Shalet, Development of a questionnaire to assess the quality of life in adults with growth hormone deficiency, Endocrinol. Metab. 2 (1995) 63-69.
36. L.C. Doward, The development of the AGHDA: a measure to assess quality of life of adults with growth hormone deficiency, Quality Life Res. 4 (1995) 420-421.
37. S.P. McKenna, L.C. Doward, What is the impact of GH deficiency and GH replacement on quality of life in childhood-onset and adult-onset GH deficiency, in: J.P. Monson (Ed.), Challenges in Growth Hormone Therapy, Blackwell Science, Oxford, UK, 1999, pp. 160-176.
38. G.A. Borkan, D.E. Hults, S.G. Gerzof, A.H. Robbins, C.K. Silbert, Age related changes in body composition revealed by computed tomography, J. Gerontol. 38 (1983) 673-677.
39. R. Abs, B.-Å. Bengtsson, E. Hernberg-Ståhl, J.P. Monson, J.-P. Tauber, P. Wilton, C. Wüster, GH replacement in 1034 growth hormone deficient adults: demographic and clinical characteristics, dosing and safety, Clin. Endocrinol. (Oxf.) 50 (1999) 703-714.